KR100976071B1 - 조성물 내에서의 또는 조성물에 관련된 개선책 - Google Patents

조성물 내에서의 또는 조성물에 관련된 개선책 Download PDF

Info

Publication number
KR100976071B1
KR100976071B1 KR1020047012429A KR20047012429A KR100976071B1 KR 100976071 B1 KR100976071 B1 KR 100976071B1 KR 1020047012429 A KR1020047012429 A KR 1020047012429A KR 20047012429 A KR20047012429 A KR 20047012429A KR 100976071 B1 KR100976071 B1 KR 100976071B1
Authority
KR
South Korea
Prior art keywords
composition
alginate
bicarbonate
carbonate
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020047012429A
Other languages
English (en)
Korean (ko)
Other versions
KR20040086364A (ko
Inventor
엑스포드소피유지니
딕슨폴앤드류
졸리프이안고든
미르볼드롤프
마샬폴
Original Assignee
레킷트 벵키저 헬스케어(유케이)리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 레킷트 벵키저 헬스케어(유케이)리미티드 filed Critical 레킷트 벵키저 헬스케어(유케이)리미티드
Publication of KR20040086364A publication Critical patent/KR20040086364A/ko
Application granted granted Critical
Publication of KR100976071B1 publication Critical patent/KR100976071B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
KR1020047012429A 2002-02-12 2003-02-07 조성물 내에서의 또는 조성물에 관련된 개선책 Expired - Fee Related KR100976071B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0203269A GB2384986B (en) 2002-02-12 2002-02-12 Compositions for the treatment of disorders of the upper gastrointestinal tract
GB0203269.6 2002-02-12
PCT/GB2003/000593 WO2003068246A2 (en) 2002-02-12 2003-02-07 Improvements in or relating to compositions

Publications (2)

Publication Number Publication Date
KR20040086364A KR20040086364A (ko) 2004-10-08
KR100976071B1 true KR100976071B1 (ko) 2010-08-17

Family

ID=9930901

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020047012429A Expired - Fee Related KR100976071B1 (ko) 2002-02-12 2003-02-07 조성물 내에서의 또는 조성물에 관련된 개선책

Country Status (17)

Country Link
US (1) US20050069583A1 (https=)
EP (1) EP1474154B1 (https=)
JP (1) JP4276545B2 (https=)
KR (1) KR100976071B1 (https=)
CN (1) CN1315483C (https=)
AT (1) ATE297742T1 (https=)
AU (1) AU2003205868B2 (https=)
CA (1) CA2474520C (https=)
DE (1) DE60300862T2 (https=)
ES (1) ES2242939T3 (https=)
GB (1) GB2384986B (https=)
MX (1) MXPA04007779A (https=)
PL (1) PL210931B1 (https=)
PT (1) PT1474154E (https=)
RU (1) RU2317087C2 (https=)
WO (1) WO2003068246A2 (https=)
ZA (1) ZA200405848B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
JP2006342085A (ja) * 2005-06-08 2006-12-21 Kao Corp Ｇｉｐ分泌抑制剤
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
EP1859786A1 (en) * 2006-05-16 2007-11-28 Frutarom Netherlands B.V. A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides
KR100919508B1 (ko) * 2007-08-14 2009-09-28 강원대학교산학협력단 매트릭스에 칼슘 카보네이트를 함유한 알지네이트 입자 및그 제조방법
GB0814376D0 (en) * 2008-08-06 2008-09-10 Reckitt Benckiser Healthcare Formulation
WO2010092468A1 (en) * 2009-02-13 2010-08-19 Carlo Ghisalberti Composition comprising alginates and d-limonene to treat gerd and dyspepsia
WO2010108494A1 (en) * 2009-03-25 2010-09-30 S-Biotek Holding Aps Dayspepsia treatment with alginate
JP5909851B2 (ja) * 2010-02-24 2016-04-27 大正製薬株式会社 易嚥下性錠剤
KR20130091250A (ko) * 2010-04-23 2013-08-16 에스-바이오텍 홀딩 에이피에스 위산 중화용 고체 약학 조성물
KR101307293B1 (ko) * 2011-05-24 2013-09-26 주식회사 인트로팜텍 알긴산 화합물을 포함하는 과립형 약학 조성물, 및 이의 제조방법
LT2806880T (lt) 2012-01-27 2017-08-25 Institute Of Bioorganic Chemistry Farmacinė kompozicija, kaip substancija antacidiniam vaistui nuo refliukso
FR3068039B1 (fr) 2017-06-22 2020-07-10 Jellynov Composition auto-moussante en milieu acide et procede de preparation
CN110945063B (zh) 2017-07-20 2022-08-16 索尔维公司 作为发泡剂的官能化的微粒碳酸氢盐、含有其的可发泡聚合物组合物及其在制造热塑性发泡聚合物中的用途
IT201800002625A1 (it) * 2018-02-13 2019-08-13 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione in forma solida per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico
IL312094A (en) * 2018-03-02 2024-06-01 Pharagen Llc Formulations treating acid reflux comprising sodium alginate
MX2024007707A (es) 2021-12-22 2024-07-01 Chemo Res S L Producto de goma de mascar antiacida que no se traga, procedimiento para su preparacion y usos del mismo.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011668A1 (en) * 1993-10-29 1995-05-04 Reckitt & Colman Products Limited Gelatin capsule fill able to foam

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
DE3580384D1 (de) * 1984-04-09 1990-12-13 Toyo Boseki Praeparat mit verzoegerter freigabe zum aufbringen auf die schleimhaeute der mundhoehle.
US4818518A (en) * 1984-11-16 1989-04-04 Uop Effervescent dentifrice
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
US5817294A (en) * 1990-11-02 1998-10-06 Arnold; Michael J. Plaque adsorbent oral composition and method
US5922351A (en) * 1991-03-27 1999-07-13 Bayer Corporation Lubricants for use in tabletting
HU213203B (en) * 1991-04-04 1997-03-28 Procter & Gamble Process for producing of ingestible pharmaceutical compositions comprising 3-(i-menthoxy)-propane-1,2-diol for treating upper gastrointestinal tract symptoms
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US5908636A (en) * 1996-06-28 1999-06-01 Mcneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form containing an antiflatulent
US6395307B1 (en) * 1997-04-30 2002-05-28 Reckitt Benckiser (Uk) Limited Pourable alginate compositions
US6210699B1 (en) * 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011668A1 (en) * 1993-10-29 1995-05-04 Reckitt & Colman Products Limited Gelatin capsule fill able to foam

Also Published As

Publication number Publication date
GB2384986A (en) 2003-08-13
DE60300862D1 (de) 2005-07-21
MXPA04007779A (es) 2004-10-15
GB0203269D0 (en) 2002-03-27
WO2003068246A2 (en) 2003-08-21
JP2005517037A (ja) 2005-06-09
PT1474154E (pt) 2005-10-31
DE60300862T2 (de) 2006-05-11
JP4276545B2 (ja) 2009-06-10
CN1630523A (zh) 2005-06-22
AU2003205868A1 (en) 2003-09-04
RU2004127245A (ru) 2005-04-10
ES2242939T3 (es) 2005-11-16
AU2003205868B2 (en) 2007-05-17
EP1474154B1 (en) 2005-06-15
GB2384986B (en) 2004-01-07
PL210931B1 (pl) 2012-03-30
WO2003068246A3 (en) 2003-12-18
CA2474520C (en) 2012-04-10
PL370141A1 (en) 2005-05-16
RU2317087C2 (ru) 2008-02-20
EP1474154A2 (en) 2004-11-10
CA2474520A1 (en) 2003-08-21
US20050069583A1 (en) 2005-03-31
CN1315483C (zh) 2007-05-16
KR20040086364A (ko) 2004-10-08
ATE297742T1 (de) 2005-07-15
ZA200405848B (en) 2006-05-31

Similar Documents

Publication Publication Date Title
KR100976071B1 (ko) 조성물 내에서의 또는 조성물에 관련된 개선책
CA2371031C (en) Compositions for treatment of disorders of the oesophagus
AU712464B2 (en) Improvements in or relating to organic compositions
AU2006271314B2 (en) Gastroretentive formulations and manufacturing process thereof
KR20100126266A (ko) 약학 조성물
EP1919487B1 (en) Particulate compositions comprising alginate and/or alginic acid
EP1891936A1 (de) Gut schluckbare pharmazeutische Zusammensetzung aus einem oder mehreren wirkstoffhaltigen Teilchen ohne unangenehmes Mundgefühl
AU2006341307B2 (en) Particulate compositions comprising alginate and/or alginic acid
WO2022144826A1 (en) New combinations and compositions of sucralfate in alginate and their use in therapy
JP2023125300A (ja) 湿製錠剤及び湿製錠剤の製造方法
HK1123192A (en) Particulate compositions comprising alginate and/or alginic acid
MXPA01011235A (es) Composiciones para el tratamiento de trastornos del esofago

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20130725

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20140724

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20150724

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20160726

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20170719

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20180811

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20180811